However, given the complex and interconnected nature of AD pathogenesis, current research is increasingly focused on developing multi-target therapeutic strategies aimed at simultaneously modulating Aβ and tau pathology, reducing oxidative stress, mitigating neuroinflammation, and restoring mitochondrial and synaptic function [14]. Here, MAPT is linked to Alzheimer disease.